The University of Chicago Header Logo

Connection

David A. Ehrmann to Plasminogen Activator Inhibitor 1

This is a "connection" page, showing publications David A. Ehrmann has written about Plasminogen Activator Inhibitor 1.
  1. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997 Jul; 82(7):2108-16.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.